Purchase Order 36C10X22P0119
Award Date
9/27/22
Potential Completion Date
9/26/25
Potential Value
$6.5M
Federal Agency
VA Strategic Acquisition Center Frederick
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Temple City, CA 91780, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,849,000.00 Firm Fixed Price Delivery Order contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The contract provides for GERMLINE PGX MOLECULAR TESTING services with a period of performance through September 29, 2029. This award is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract held by Fulgent Genetics with...
This is a firm fixed price definitive contract awarded by the Veterans Integrated Service Network 17 of the Department of Veterans Affairs to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for $1,010,000.00 and has a period of performance through September 30, 2028. The contract is for genetics testing services, including clinical genetic testing, germline genetic testing utilizing whole genome sequencing, custom gene...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for germline genetic testing services. The contract has a ceiling value of $95,817.89 and a period of performance through September 30, 2018. It was awarded as a total small business set-aside. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits and services to various federal agencies, including the VA,...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for the delivery of laboratory testing kits, with a ceiling value of $889,097.43 and a period of performance through December 30, 2024. There was no set-aside designation used for this award. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits...
The Department of Veterans Affairs Veterans Health Administration awarded Fulgent Therapeutics LLC a $3.2 million firm fixed price delivery order against its Medical Laboratory Testing and Analysis Services GSA Schedule contract. Fulgent Therapeutics, doing business as Fulgent Diagnostics and a division of Fulgent Genetics, will provide COVID-19 cost per test services to VHA's Veterans Integrated Service Network 21 through December 2020. The contract supports VHA's coronavirus disease testing...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $104,500 firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for the procurement of next generation DNA sequencing services. Fulgent Therapeutics is a subsidiary of Fulgent Genetics, Inc. and has previously provided genetic and genomic testing services to various federal agencies, including the...
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services. The contract, valued at $135,528.64, is for Next Generation Sequencing (NGS) testing services to support the VA's National Precision Oncology Program at the Richard L. Roudebush VA Medical Center. The contract is a Firm Fixed Price Delivery Order issued under a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed price contract awarded by the Department of Veterans Affairs Veterans Health Administration to Invitae Corporation, doing business as Invitae, for $748,475.00. The contract is for germline genetic testing services, including next-generation sequencing, deletion/duplication analysis, and variant confirmation, to be delivered to VA medical facilities across the United States through September 2019. Invitae is a genetic testing and information company that has received multiple...
This firm fixed-price purchase order for $84,150 was awarded by the Department of Veterans Affairs (VA) to Invitae Corporation, a for-profit genetic testing company, to provide genetic testing services in support of the VA's Million Veteran Program (MVP) and MVP-ROAR study. The contract will run from July 2020 through July 2025 and does not have a set-aside designation. Under this contract, Invitae will perform DNA sequencing, analysis, interpretation, and reporting of genetic tests for the...
This federal contract award was issued by the Veterans Integrated Service Network 6 (VISN 6), a division of the U.S. Department of Veterans Affairs (VA), to Prevention Genetics LLC, a for-profit limited liability company that provides genetic testing services. The $55,800 firm-fixed-price purchase order is for the provision of genetic testing panels, excluding exome testing, with a period of performance through March 21, 2024. The original solicitation was issued by the Richmond VA Medical...